...plc (LSE:IVO). Other investors include Consort Medical plc , NeoMed, V-Bio Ventures and manufacturing company Hovione...

...Invion and Hovione partnered to develop a dry powder formulation of Invion’s asthma candidate INV104 (zafirlukast...
...INV104 (zafirlukast) delivered using Hovione’s inhaler. Invion is responsible for development and regulatory submissions, and Hovione...
...Accolade Pharmaceuticals LLC (Wilmington, Del.) in October 2013. The partners declined to provide financial details. Hovione Farmaciencia SA...

...Sankyo and BTA received a license to use Hovione's dry powder inhaler technology to deliver long-acting...
...in a prototype inhaler. The companies expect to begin Phase I testing of CS-8958 with Hovione's...
...BTA's LANIs in Japan (see BioCentury, April 3, 2006). Biota Holdings Ltd. (ASX:BTA), Melbourne, Australia Hovione...

...cancer. The trial is expected to complete enrollment in the second half of next year. Hovione...
...previously has produced clinical trial quantities of the compound. Allos Therapeutics Inc. (ALTH), Westminster, Colo. Hovione...

...improved formulations of six unnamed off-patent drugs using CyDex's Captisol sulfobutylether beta-cyclodextrin drug delivery technology. Hovione...
...that complexes water insoluble active compounds in its central cavity. CyDex Inc. , Lenexa, Kan. Hovione...